Supplementary prescribing by community and primary care pharmacists

An analysis of PACT data, 2004--2006

L Guillaume, R Cooper, A Avery, S Mitchell, P Ward, C Anderson, Paul Bissell, A Hutchinson, V James, J Lymn, Aileen McIntosh, Elizabeth Murphy, Julie Ratcliffe

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Background and objective:  Pharmacist prescribing is a relatively new intiative in the extension of prescribing responsibilities to non-medical healthcare professionals. Pharmacist supplementary prescribing was introduced in 2003 and allowed prescribing in accordance with a clinical management plan agreed with a medical practitioner and patient to improve patient access to medicines and better utilize the skills of healthcare professionals. The objective of this research was to examine the volume, cost and trends in pharmacist prescribing in community and primary care using Prescription Analysis and Cost (PACT) data and to suggest possible reasons for the trends.

Methods:  Using PACT data at national, chapter and subchapter level for 2004–2006 the volume, costs and trends for pharmacist prescribing were obtained. Supplemental data and statistical analysis from other sources, relating to prescribing of individual drugs, were also utilized.

Results:  The total number of items prescribed by pharmacists in community and primary care increased from 2706 in 2004 to 31 052 in 2006. In 2006, pharmacist prescribing represented only 0·004% of all prescribing in the community and primary care setting. Cardiovascular medicines were the most frequently prescribed therapeutic class followed by central nervous system, respiratory, endocrine and gastrointestinal medicines.

Conclusion:  Pharmacist prescribing is increasing but represents an extremely small proportion of primary care prescribing. PACT data between 2004 and 2006 reflects pharmacist supplementary prescribing alone and has been in the anticipated therapeutic areas of drugs which treat chronic conditions such as hypertension.
Original languageEnglish
Pages (from-to)11-16
Number of pages6
JournalJournal of Clinical Pharmacy and Therapeutics
Volume33
Issue number1
DOIs
Publication statusPublished - Jan 2008
Externally publishedYes

Fingerprint

Pharmacists
Prescriptions
Primary Health Care
Costs and Cost Analysis
Delivery of Health Care
Drug Prescriptions
Statistical Data Interpretation
Central Nervous System
Hypertension
Therapeutics
Research
Pharmaceutical Preparations

Cite this

Guillaume, L ; Cooper, R ; Avery, A ; Mitchell, S ; Ward, P ; Anderson, C ; Bissell, Paul ; Hutchinson, A ; James, V ; Lymn, J ; McIntosh, Aileen ; Murphy, Elizabeth ; Ratcliffe, Julie. / Supplementary prescribing by community and primary care pharmacists : An analysis of PACT data, 2004--2006. In: Journal of Clinical Pharmacy and Therapeutics. 2008 ; Vol. 33, No. 1. pp. 11-16.
@article{df89e663d2fa4f4e8ef203978db3d2d9,
title = "Supplementary prescribing by community and primary care pharmacists: An analysis of PACT data, 2004--2006",
abstract = "Background and objective:  Pharmacist prescribing is a relatively new intiative in the extension of prescribing responsibilities to non-medical healthcare professionals. Pharmacist supplementary prescribing was introduced in 2003 and allowed prescribing in accordance with a clinical management plan agreed with a medical practitioner and patient to improve patient access to medicines and better utilize the skills of healthcare professionals. The objective of this research was to examine the volume, cost and trends in pharmacist prescribing in community and primary care using Prescription Analysis and Cost (PACT) data and to suggest possible reasons for the trends.Methods:  Using PACT data at national, chapter and subchapter level for 2004–2006 the volume, costs and trends for pharmacist prescribing were obtained. Supplemental data and statistical analysis from other sources, relating to prescribing of individual drugs, were also utilized.Results:  The total number of items prescribed by pharmacists in community and primary care increased from 2706 in 2004 to 31 052 in 2006. In 2006, pharmacist prescribing represented only 0·004{\%} of all prescribing in the community and primary care setting. Cardiovascular medicines were the most frequently prescribed therapeutic class followed by central nervous system, respiratory, endocrine and gastrointestinal medicines.Conclusion:  Pharmacist prescribing is increasing but represents an extremely small proportion of primary care prescribing. PACT data between 2004 and 2006 reflects pharmacist supplementary prescribing alone and has been in the anticipated therapeutic areas of drugs which treat chronic conditions such as hypertension.",
author = "L Guillaume and R Cooper and A Avery and S Mitchell and P Ward and C Anderson and Paul Bissell and A Hutchinson and V James and J Lymn and Aileen McIntosh and Elizabeth Murphy and Julie Ratcliffe",
year = "2008",
month = "1",
doi = "10.1111/j.1365-2710.2008.00869.x",
language = "English",
volume = "33",
pages = "11--16",
journal = "Journal of Clinical Pharmacy and Therapeutics",
issn = "0269-4727",
publisher = "Wiley-Blackwell Publishing Ltd.",
number = "1",

}

Guillaume, L, Cooper, R, Avery, A, Mitchell, S, Ward, P, Anderson, C, Bissell, P, Hutchinson, A, James, V, Lymn, J, McIntosh, A, Murphy, E & Ratcliffe, J 2008, 'Supplementary prescribing by community and primary care pharmacists: An analysis of PACT data, 2004--2006', Journal of Clinical Pharmacy and Therapeutics, vol. 33, no. 1, pp. 11-16. https://doi.org/10.1111/j.1365-2710.2008.00869.x

Supplementary prescribing by community and primary care pharmacists : An analysis of PACT data, 2004--2006. / Guillaume, L; Cooper, R; Avery, A; Mitchell, S; Ward, P; Anderson, C; Bissell, Paul; Hutchinson, A; James, V; Lymn, J; McIntosh, Aileen; Murphy, Elizabeth; Ratcliffe, Julie.

In: Journal of Clinical Pharmacy and Therapeutics, Vol. 33, No. 1, 01.2008, p. 11-16.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Supplementary prescribing by community and primary care pharmacists

T2 - An analysis of PACT data, 2004--2006

AU - Guillaume, L

AU - Cooper, R

AU - Avery, A

AU - Mitchell, S

AU - Ward, P

AU - Anderson, C

AU - Bissell, Paul

AU - Hutchinson, A

AU - James, V

AU - Lymn, J

AU - McIntosh, Aileen

AU - Murphy, Elizabeth

AU - Ratcliffe, Julie

PY - 2008/1

Y1 - 2008/1

N2 - Background and objective:  Pharmacist prescribing is a relatively new intiative in the extension of prescribing responsibilities to non-medical healthcare professionals. Pharmacist supplementary prescribing was introduced in 2003 and allowed prescribing in accordance with a clinical management plan agreed with a medical practitioner and patient to improve patient access to medicines and better utilize the skills of healthcare professionals. The objective of this research was to examine the volume, cost and trends in pharmacist prescribing in community and primary care using Prescription Analysis and Cost (PACT) data and to suggest possible reasons for the trends.Methods:  Using PACT data at national, chapter and subchapter level for 2004–2006 the volume, costs and trends for pharmacist prescribing were obtained. Supplemental data and statistical analysis from other sources, relating to prescribing of individual drugs, were also utilized.Results:  The total number of items prescribed by pharmacists in community and primary care increased from 2706 in 2004 to 31 052 in 2006. In 2006, pharmacist prescribing represented only 0·004% of all prescribing in the community and primary care setting. Cardiovascular medicines were the most frequently prescribed therapeutic class followed by central nervous system, respiratory, endocrine and gastrointestinal medicines.Conclusion:  Pharmacist prescribing is increasing but represents an extremely small proportion of primary care prescribing. PACT data between 2004 and 2006 reflects pharmacist supplementary prescribing alone and has been in the anticipated therapeutic areas of drugs which treat chronic conditions such as hypertension.

AB - Background and objective:  Pharmacist prescribing is a relatively new intiative in the extension of prescribing responsibilities to non-medical healthcare professionals. Pharmacist supplementary prescribing was introduced in 2003 and allowed prescribing in accordance with a clinical management plan agreed with a medical practitioner and patient to improve patient access to medicines and better utilize the skills of healthcare professionals. The objective of this research was to examine the volume, cost and trends in pharmacist prescribing in community and primary care using Prescription Analysis and Cost (PACT) data and to suggest possible reasons for the trends.Methods:  Using PACT data at national, chapter and subchapter level for 2004–2006 the volume, costs and trends for pharmacist prescribing were obtained. Supplemental data and statistical analysis from other sources, relating to prescribing of individual drugs, were also utilized.Results:  The total number of items prescribed by pharmacists in community and primary care increased from 2706 in 2004 to 31 052 in 2006. In 2006, pharmacist prescribing represented only 0·004% of all prescribing in the community and primary care setting. Cardiovascular medicines were the most frequently prescribed therapeutic class followed by central nervous system, respiratory, endocrine and gastrointestinal medicines.Conclusion:  Pharmacist prescribing is increasing but represents an extremely small proportion of primary care prescribing. PACT data between 2004 and 2006 reflects pharmacist supplementary prescribing alone and has been in the anticipated therapeutic areas of drugs which treat chronic conditions such as hypertension.

U2 - 10.1111/j.1365-2710.2008.00869.x

DO - 10.1111/j.1365-2710.2008.00869.x

M3 - Article

VL - 33

SP - 11

EP - 16

JO - Journal of Clinical Pharmacy and Therapeutics

JF - Journal of Clinical Pharmacy and Therapeutics

SN - 0269-4727

IS - 1

ER -